Form 4: Biohaven Director Irina Antonijevic Acquires Stock Options
SEC Form 4
Director Irina Antonijevic acquired 16,592 stock options in Biohaven Ltd. on April 30, 2024.
Summary
- On April 30, 2024, Irina Antonijevic, a director of Biohaven Ltd., acquired 16,592 stock options.
- The exercise price of these options is $38.80.
- The options vest on the earlier of April 30, 2025, or the date of the 2025 Annual Meeting of Shareholders, contingent upon continuous service with the issuer.
- Following the transaction, Antonijevic directly owns 16,592 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock option grants, which is neutral in sentiment.
Future Outlook
The stock options will vest on the earlier of April 30, 2025, or the date of the 2025 Annual Meeting of Shareholders, contingent upon continuous service with the issuer.
Industry Context
This is a standard Form 4 filing, reflecting a change in beneficial ownership by a company insider. It is common for directors and officers to receive stock options as part of their compensation.
Stakeholder Impact
- The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment, as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/30/2024 | Date of transaction: Irina Antonijevic acquired 16,592 stock options. |
| 04/30/2025 | Earliest vesting date for the stock options, contingent upon continuous service. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.